Prenatal Exposure to Endocrine-Disrupting Chemicals Affects Child's Metabolic Health
By Elana Gotkine HealthDay Reporter
FRIDAY, May 24, 2024 -- Prenatal exposure to endocrine-disrupting chemicals (EDCs) is associated with adverse metabolic health in children, according to a study published online May 23 in JAMA Network Open.
Nuria Güil-Oumrait, from the Barcelona Institute for Global Health in Spain, and colleagues examined associations of prenatal exposure to EDC mixtures with the metabolic syndrome (MetS) risk score in children in a population-based, birth cohort study. Mother-child pairs with measured prenatal EDC exposures and complete data on childhood MetS risk factors, proteins, and metabolites were included; the study included 1,134 mothers and their children.
The researchers found that for each one-quartile increase of the mixture for metals, organochlorine pesticides, polybrominated diphenyl ethers, and perfluoroalkyl substances, there was an increase in the MetS score, constructed at 6 to 11 years of age (β = 0.44, 0.22, 0.17, and 0.19, respectively). Associations were seen for high-molecular weight phthalate mixture and low-molecular-weight phthalate mixtures with a reduced MetS score (β = −0.07 and −0.13, respectively). Elevated proinflammatory proteins, amino acids, and altered glycerophospholipids, which were associated with an increased MetS score, were seen in association with most EDC mixtures.
"These findings advance our limited understanding of metabolic effects of EDC mixtures in early life and can inform more efficient early-life prevention and intervention strategies to address rising trends in MetS across the life course," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Epidural Analgesia Linked to Decline in Severe Maternal Morbidity
FRIDAY, May 24, 2024 -- Epidural analgesia during labor is associated with a reduction in severe maternal morbidity (SMM), according to a study published online May 22 in The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.